Skip to main content
. 2023 Jul 3;10(6):555–564. doi: 10.1093/nop/npad037

Figure 3.

Figure 3.

(A) Overall survival of 1451 patients with glioblastoma undergoing resection analyzed according to extent of resection (CRCET; complete resection of contrast-enhancing tumor). (B) Overall survival of 386 patients with glioblastoma where CRCET was achieved analyzed according to time period. (C) Overall survival of 965 patients with glioblastoma where subtotal resection of contrast-enhancing tumor was achieved analyzed according to time period.